Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cosmos Health (COSM) Depreciation & Amortization - Total (2016 - 2024)

Cosmos Health (COSM) has disclosed Depreciation & Amortization - Total for 10 consecutive years, with $80910.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Depreciation & Amortization - Total fell 29.99% year-over-year to $80910.0, compared with a TTM value of $80910.0 through Sep 2025, down 80.81%, and an annual FY2024 reading of $387036.0, up 9.63% over the prior year.
  • Depreciation & Amortization - Total was $80910.0 for Q4 2024 at Cosmos Health, down from $89694.0 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $124910.0 in Q2 2023 and bottomed at -$178561.0 in Q4 2022.
  • Average Depreciation & Amortization - Total over 5 years is $72419.2, with a median of $80743.0 recorded in 2022.
  • The sharpest move saw Depreciation & Amortization - Total soared 496.5% in 2020, then crashed 277.37% in 2022.
  • Year by year, Depreciation & Amortization - Total stood at $57730.0 in 2020, then skyrocketed by 74.39% to $100673.0 in 2021, then plummeted by 277.37% to -$178561.0 in 2022, then soared by 164.72% to $115564.0 in 2023, then decreased by 29.99% to $80910.0 in 2024.
  • Business Quant data shows Depreciation & Amortization - Total for COSM at $80910.0 in Q4 2024, $89694.0 in Q3 2024, and $103558.0 in Q2 2024.